← All indications
Cocaine-Related Disorders
Disorders related or resulting from use of cocaine.
Drugs by status
Approved for this indication (1)
Phase 4 trials (12)
Phase 3 trials (18)
Phase 2 trials (79)
- flupentixol
- 18f fluortriopride
- acamprosate
- mavoglurant
- lorcaserin
- buspirone
- benzatropine
- candesartan
- cariprazine
- citalopram
- clavulanate
- diphenhydramine
- exenatide
- cycloserine
- d-serine
- prednisone
- valproic acid
- suvorexant
- cannabidiol
- galantamine
- gabapentin
- sertraline
- mesalamine
- guanfacine
- amantadine
- lorazepam
- levetiracetam
- l-tetrahydropalmatine
- tryptophan
- labetalol
- +49 more
Phase 1 trials (38)
- piracetam
- samidorphan
- phentermine
- acetazolamide
- tozadenant
- benzoylecgonine ethyl ester
- lisuride
- cpp-115
- duloxetine
- hydrocortisone
- jdtic
- lofexidine
- nop-1a
- phendimetrazine
- raclopride
- immune globulin (human)
- riluzole
- rivastigmine
- rti-336
- tolcapone
- clonidine
- hydromorphone
- pentoxifylline
- vanoxerine
- calcitriol
- zolmitriptan
- dad5gne vaccine
- dexmedetomidine
- naloxone
- pramipexole
- +8 more
Organizations
Organization Involved with Phase 4 Indications (15)
- AstraZeneca
- National Institute on Drug Abuse (NIDA)
- Swiss Federal Institute of Technology
- Federal University of Rio Grande do Sul
- University of Washington
- University of Kansas
- University of Zurich
- Columbia University
- Center for Addicitve Disorders
- Universidad Autonoma de Barcelona
- University of Paris
- Department of Veteran Affairs
- New York MDRU
- National Research Agency, France
- The University of Texas, Dallas
Organization Involved with Phase 3 Indications (18)
- Somerset Pharmaceuticals
- Catalyst Pharmaceuticals, Inc.
- The EMMES Corporation
- Research Foundation for Mental Hygiene, Inc.
- University of Pennsylvania
- Johns Hopkins University
- University of Maryland
- University of South Carolina
- Virginia Commonwealth University
- Yale University
- University of Virginia
- University of California, Los Angeles
- Medical University of South Carolina
- University of Minnesota
- University of Texas at Houston
- University of Sao Paulo
- Nacional Conseling of Scientific Development and Technology, Brazil
- Association for Psychopharmacological Research, Brazil
Organization Involved with Phase 2 Indications (44)
- Eli Lilly
- Novartis
- Alkermes
- Biotie Therapies
- Celtic Pharma Development Services
- Indivior Inc.
- Saniona
- Teva
- Friends Research Institute, Inc.
- The Dana Foundation
- Midwest Biomedical Research Foundation
- National Institutes of Health (NIH)
- French National Agency for Research on AIDS and Viral Hepatitis
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Baylor University
- Boston University
- Brown University
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Harvard University
- Duke University
- Hoosier Cancer Research Network
- Mclean Hospital
- New York University
- University of Kentucky
- University of Miami
- University of Vermont
- Denver Research Institute
- University of Cincinnati
- Canadian Research Initiative in Substance Misuse
- University of Basel
- +14 more
Organization Involved with Phase 1 Indications (11)
Organization Involved with Other Experimental Indications (7)